Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • ORAL IRON-HYDROXIDE POLYMALTOSE COMPLEX VERSUS SUCROSOMIAL IRON FOR CHILDREN WITH IRON DEFICIENCY WITH OR WITHOUT ANEMIA: A CLINICAL TRIAL WITH EMPHASIS ON INTESTINAL INFLAMMATION

    Miss Sonia Alexiadou, Mrs. Christina Tsigalou, Mrs. Eleni Kourkouni, Professor Aggelos Tsalkidis, Professor Elpis Mantadakis
    e2024075
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.075
    1719
    PDF: 846
    HTML: 615
  • COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

    Federico Mercolini, Simone Cesaro
    e2022009
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.009
    2572
    PDF: 959
    HTML: 319
  • Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio

    Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna
    e2025006
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.006
    2221
    PDF: 1631
    HTML: 321
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1940
    PDF: 1032
    HTML: 1358
  • ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

    Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko
    e2018014
    2018-02-15
    https://doi.org/10.4084/mjhid.2018.014
    5312
    PDF: 1969
    HTML: 1404
  • ANTIFUNGAL SUSCEPTIBILITY TESTING: CURRENT ROLE FROM THE CLINICAL LABORATORY PERSPECTIVE

    Brunella Posteraro, Riccardo Torelli, Elena De Carolis, Patrizia Posteraro, Maurizio Sanguinetti
    e2014030
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.030
    2016
    PDF: 1304
    HTML: 6431
  • LIVER IRON CONTENT (LIC) IN ADULTS WITH NON-TRANSFUSION DEPENDENT SICKLE CELL DISEASE (NT-SCD). CORRELATION WITH SERUM FERRITIN AND LIVER ENZYMES CONCENTRATIONS

    Vincenzo De Sanctis
    e2017037
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.037
    3970
    PDF: 997
    HTML: 1155
  • DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.

    Maria Concetta Postorino, Filippo Luciani, Carmelo Mangano, Maria Stella Carpentieri, Paolo Scerbo, Armando Priamo, Giuseppina Berardelli, Roberto Marino, Alfredo Vallone, Nicola Serrao, Vincenzo Pisani, Chiara Costa, Albano Terremoto, Giuseppe Foti, Lucio Cosco, Massimo Calderazzo, Domenico Corigliano, Preziosa Scordo, Carlo Torti, Alessio Strazzulla
    e2015054
    2015-10-08
    https://doi.org/10.4084/mjhid.2015.054
    1633
    PDF: 818
    HTML: 1242
    Figure 1: 182
    Figure 2: 196
    Figure 3: 193
  • CAR-T cells microscopic and phenotypic identification in the peripheral blood CAR-T cells in the PB

    LESESVE
    e2022024
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.024
    1744
    PDF: 672
    HTML: 209
  • TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

    Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD
    e2022018
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.018
    1927
    PDF: 793
    HTML: 547
  • RISK FACTORS ASSOCIATED WITH MORTALITY IN NOSOCOMIAL STENOTROPHOMONAS MALTOPHILIA PNEUMONIA: A SINGLE-CENTER RETROSPECTIVE STUDY-

    Yeşim Yıldız, Özge Özgen Top, Pınar Aysert Yıldız, Dr. Tekin Tas, Sedanur Eser, Hamid Habibi, Murat Dizbay
    e2026018
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.018
    554
    PDF: 550
    HTML: 80
  • Severe CMV infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in an old mantle cell lymphoma patient

    Gabriele Magliano, Annarosa Cuccaro, Francesco D'Alo', Elena Maiolo, Silvia Bellesi, Stefan Hohaus, Andrea Bacigalupo, Livio Pagano
    e2021054
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.054
    1271
    PDF: 452
    HTML: 175
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1124
    PDF: 631
    HTML: 4424
  • BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

    Giuseppe Leone, Eligio Pizzigallo
    e2015057
    2015-10-12
    https://doi.org/10.4084/mjhid.2015.057
    4958
    PDF: 2000
    HTML: 8442
  • Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease

    Marco Marziali, Antonella Isgrò, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Cecilia Alfieri, Andrea Roveda, Gioia De Angelis, Luisa Cardarelli, Michela Ribersani, Marco Andreani, Guido Lucarelli
    e2014066
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.066
    1668
    PDF: 1020
    HTML: 1886
    Untitled: 205
    Untitled: 189
  • Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital inRome

    alessandro andriani, Laura Marchetti, Fabio Rossi, Silvia Raja, Maria Antonietta Perretti, Umberto Recine
    e2024030
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.030
    645
    PDF: 1050
    HTML: 99
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

    Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli
    e2009027
    2009-12-26
    1730
    PDF: 734
    HTML: 2923
  • Hepatocellular carcinoma in a non-cirrhotic liver of a HCV-positive woman with sustained viral response

    Lorenzo Nosotti, D'Arca Teresa, Massimo Marignani, Genoveffa Balducci, Gianfranco Costanzo, Concetta Mirisola
    e2011050
    2011-10-26
    https://doi.org/10.4084/mjhid.2011.050
    1631
    PDF: 799
    HTML: 382
  • CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN

    S Menascu, A Lotan, B Ben Zeev, U Nowak- Gottl, G Kenet
    e2011029
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.029
    2540
    PDF: 969
    HTML: 2245
  • Systemic lupus erythematosus, complicated by nephritis and macrophage activation syndrome, not responsive to high-dose immunosuppression

    Ioanna Saougou, Alexandros Makis
    e2026054
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.054
    163
    PDF: 111
    HTML: 60
  • BING-NEEL SYNDROME: ILLUSTRATIVE CASES AND COMPREHENSIVE REVIEW OF THE LITERATURE

    Marzia Varettoni, Irene Defrancesco, Luca Diamanti, Enrico Marchioni, Lisa Maria Farina, Anna Pichiecchio
    e2017061
    2017-10-18
    https://doi.org/10.4084/mjhid.2017.061
    3522
    PDF: 1523
    HTML: 1337
  • Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series

    Shahrzad Zonoozi
    e2017004
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.004
    3001
    PDF: 1000
    HTML: 1299
  • OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Paola Angelini, Laura Rodriguez, Mohammed Zolaly, Ahmed Naqvi, Sheila Weitzman, oussama Abla, Angela Punnett
    e2018020
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.020
    2908
    PDF: 855
    HTML: 381
  • ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

    Maria L. Delioukina, Stephen J. Forman
    e2010018
    2010-06-30
    https://doi.org/10.4084/mjhid.2010.018
    1270
    PDF: 801
    HTML: 547
  • BETA THALASSEMIA MAJOR IN A DEVELOPING COUNTRY: EPIDEMIOLOGICAL, CLINICAL AND EVOLUTIONARY ASPECT

    Mohamed Bejaoui, Naouel Guirat
    e2013002
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.002
    1648
    PDF: 915
    HTML: 2516
  • RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

    Julie Schanz, Friederike Braulke, Detlef Haase
    e2015034
    2015-04-23
    https://doi.org/10.4084/mjhid.2015.034
    3856
    PDF: 1698
    HTML: 11658
    Figures Haase: 218
  • LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT

    Fabian Herrera
    e2024039
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.039
    1337
    PDF: 1030
    HTML: 127
  • Concurrent diagnosis of acute myeloid leukemia and symptomatic COVID-19 infection: a case report successfully treated with Azacitidine-Venetoclax combination

    Daniela Taurino, Marco Frigeni, Anna Grassi, Gianluca Cavallaro, Silvia Salmoiraghi, Orietta Spinelli, Alessandro Rambaldi, Federico Lussana
    e2021057
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.057
    1294
    PDF: 517
    HTML: 181
  • IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS

    Alana Kennedy-Nasser, Catherine Bollard, Helen Heslop
    e2009010
    2009-11-13
    https://doi.org/10.4084/mjhid.2009.010
    1234
    PDF: 611
    HTML: 6806
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN

    Ramzi Jeddi, Hèla Ghédira, Ramzi Ben Amor, Yosr Ben Abdennebi, Kacem Karima, Zarrouk Mohamed, Hend Ben Neji, Lamia Aissaoui, Raihane Ben Lakhal, Naouel Ben Salah, Samia Menif, Zaher Belhadjali, Hela Ben Abid, Emna Gouider, Raouf Hafsia, Ali Saad, Pierre Fenaux, Balkis Meddeb
    e2011033
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.033
    4014
    PDF: 765
    HTML: 1858
  • Validation of a New Scoring System for Treatment Failure in CML Patients on Tyrosine Kinase Inhibitors in a real world setting

    Andrea Mattozzi, Eugenio Galli, Francesco Autore, Ilaria Pansini, Patrizia Chiusolo, Simona Sica, Federica Sorà
    e2026013
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.013
    622
    PDF: 526
    Html: 88
  • EFFICACY AND SAFETY OF THALIDOMIDE IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA: A SYSTEMATIC REVIEW, META-ANALYSIS AND GRADE EVALUATION

    Jialian Li, Ping Ji, Qinyue Zhong, Lin Dong, Hai Yi, Baiyu Chen, Xu Zhang, Tingting Duan
    e2026033
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.033
    274
    PDF: 286
    Suppl. Files: 46
    HTML: 41
  • HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

    Armando Tripodi
    e2024027
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.027
    1036
    PDF: 1370
    HTML: 140
  • DESCRIPTIVE EPIDEMIOLOGY OF HEMOPHILIA AND OTHER COAGULATION DISORDERS IN MANSOURA , EGYPT

    Youssef Al Tonbary, Rasha ElAshry, Maysaa El Sayed Zaki
    e2010025
    2010-08-03
    https://doi.org/10.4084/mjhid.2010.025
    1737
    PDF: 952
    HTML: 954
  • JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia

    Phakatip Sinlapamongkolkul, Pacharapan Surapolchai, Vip Viprakasit
    e2023056
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.056
    2535
    PDF: 629
    Suppl. Files: 292
    HTML: 179
  • GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

    Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau
    e2011019
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.019
    2625
    PDF: 818
    HTML: 5241
  • LATERAL SINUS THROMBOSIS IN OTOLOGY: A REVIEW

    B Visavanatha, Khaja Naseeruddin
    e2010027
    2010-09-07
    https://doi.org/10.4084/mjhid.2010.027
    1650
    PDF: 959
    HTML: 4106
    Letter: 177
  • Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center

    Muruvvet Seda Aydin, Gulten Korkmaz, Merve Pamukcuoglu, Hatice Rahmet Guner, Funda Ceran, Simten Dagdas, Gulsum Ozet
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.044
    247
    PDF: 308
    HTML: 41
  • LIVER DISEASE & SICKLE CELL DISEASE: AUTOIMMUNE HEPATITIS MORE THAN A COINCIDENCE; A SYSTEMATIC LITERATURE REVIEW.

    Kelvin Lynch, Andrea Mega, Andrea Piccin, Massimo Daves, Helen Fogarty
    e2023060
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.060
    2361
    PDF: 1207
    HTML: 258
  • SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib

    Matteo Molica
    e2024079
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.079
    966
    PDF: 527
    HTML: 217
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1437
    PDF: 759
    HTML: 309
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1270
    PDF: 489
    HTML: 169
  • BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.

    Roberto Castelli
    e2016030
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.030
    4714
    PDF: 996
    HTML: 1727
  • RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: CHEMOIMMUNOTHERAPY, TREATMENT UNTIL PROGRESSION WITH MECHANISM-DRIVEN AGENTS OR FINITE-DURATION THERAPY?

    Antonio Cuneo, Robin Foà
    e2019024
    2019-02-27
    https://doi.org/10.4084/mjhid.2019.024
    2745
    PDF: 1684
    HTML: 267
  • NOVEL DRUGS IN FOLLICULAR LYMPHOMA

    Giuseppe Rossi, Antonella Anastasia
    e2016061
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.061
    4467
    PDF: 1538
    HTML: 1564
    Untitled: 243
  • A case of central venous catheter-related Candida parapsilosis fungemia evolved to disseminated infection in a neutropenic patient with blast crisis of chronic myeloid leukemia.

    Elena Amabile, Matteo Totaro, Luca Cappelli, Clara Minotti, Alessandra Micozzi
    e2024013
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.013
    1027
    PDF: 1186
    HTML: 167
  • DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE

    avinash kumar singh, tulika seth, nita radhakrishnan, pravas mishra, manoranjan mahapatra, haraprasad pati
    e2013039
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.039
    1948
    PDF: 864
    HTML: 3599
    Diamond Blackfan Anemia: A Tertiary care centre experience: 322
  • ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME

    Teresa L Field, Claudio Anasetti
    e2010019
    2010-07-19
    https://doi.org/10.4084/mjhid.2010.019
    1384
    PDF: 686
    HTML: 1190
  • ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: A SINGLE CENTRE EXPERIENCE FROM TURKEY

    Tekin Aksu
    e2018045
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.045
    2854
    PDF: 1289
    HTML: 624
  • The COST-UTILITY ANALYSIS OF FOUR CHELATION REGIMENS FOR ?-THALASSEMIA MAJOR: A CHINESE PERSPECTIVE

    Jialian Li
    e2020029
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.029
    1874
    PDF: 986
    HTML: 282
251 - 300 of 500 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.